Free Trial

Colgate-Palmolive (NYSE:CL) Given New $83.00 Price Target at Barclays

Colgate-Palmolive logo with Consumer Staples background

Colgate-Palmolive (NYSE:CL - Get Free Report) had its price target decreased by research analysts at Barclays from $96.00 to $83.00 in a note issued to investors on Friday,Benzinga reports. The firm currently has an "equal weight" rating on the stock. Barclays's price target suggests a potential downside of 6.53% from the stock's previous close.

A number of other equities research analysts have also recently commented on CL. TD Cowen reduced their target price on shares of Colgate-Palmolive from $110.00 to $100.00 and set a "buy" rating for the company in a report on Wednesday, January 8th. JPMorgan Chase & Co. reduced their price objective on Colgate-Palmolive from $109.00 to $103.00 and set an "overweight" rating for the company in a research note on Thursday. Stifel Nicolaus cut Colgate-Palmolive from a "buy" rating to a "hold" rating and decreased their price objective for the stock from $105.00 to $101.00 in a research report on Monday, October 28th. Piper Sandler dropped their price objective on shares of Colgate-Palmolive from $121.00 to $112.00 and set an "overweight" rating on the stock in a research note on Monday, January 6th. Finally, UBS Group cut their target price on Colgate-Palmolive from $112.00 to $104.00 and set a "buy" rating for the company in a research note on Thursday. One investment analyst has rated the stock with a sell rating, ten have assigned a hold rating and twelve have given a buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of "Hold" and a consensus price target of $101.11.

Get Our Latest Report on CL

Colgate-Palmolive Trading Up 0.3 %

NYSE:CL traded up $0.23 on Friday, hitting $88.79. The stock had a trading volume of 5,149,874 shares, compared to its average volume of 3,679,883. Colgate-Palmolive has a 1-year low of $79.69 and a 1-year high of $109.30. The stock has a market cap of $72.55 billion, a price-to-earnings ratio of 25.44, a PEG ratio of 3.01 and a beta of 0.44. The company has a fifty day moving average price of $92.20 and a two-hundred day moving average price of $97.74. The company has a quick ratio of 0.68, a current ratio of 1.04 and a debt-to-equity ratio of 9.46.

Insiders Place Their Bets

In other Colgate-Palmolive news, CFO Stanley J. Sutula III sold 45,410 shares of the stock in a transaction on Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the sale, the chief financial officer now directly owns 36,726 shares of the company's stock, valued at approximately $3,456,283.86. This represents a 55.29 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 0.37% of the stock is owned by insiders.

Institutional Trading of Colgate-Palmolive

Several hedge funds have recently bought and sold shares of CL. Peak Financial Advisors LLC bought a new stake in shares of Colgate-Palmolive in the 4th quarter worth $1,315,000. Gordian Advisors LLC bought a new stake in Colgate-Palmolive in the third quarter worth approximately $602,000. Carrera Capital Advisors increased its position in Colgate-Palmolive by 23.1% during the third quarter. Carrera Capital Advisors now owns 39,170 shares of the company's stock worth $4,066,000 after buying an additional 7,353 shares during the last quarter. Vontobel Holding Ltd. lifted its holdings in Colgate-Palmolive by 224.6% in the 3rd quarter. Vontobel Holding Ltd. now owns 795,938 shares of the company's stock worth $82,626,000 after purchasing an additional 550,750 shares during the last quarter. Finally, Fiduciary Alliance LLC bought a new stake in shares of Colgate-Palmolive during the 4th quarter worth $4,066,000. 80.41% of the stock is currently owned by institutional investors.

About Colgate-Palmolive

(Get Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Featured Stories

Analyst Recommendations for Colgate-Palmolive (NYSE:CL)

Should You Invest $1,000 in Colgate-Palmolive Right Now?

Before you consider Colgate-Palmolive, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Colgate-Palmolive wasn't on the list.

While Colgate-Palmolive currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Transportation Stocks to Watch in 2025: Top Picks for Growth
Crypto Boom 2025: Bitcoin’s Rise and Trump’s Impact on the Market
Goldman Sachs’ 2025 Market Outlook: Top 3 Stock Picks

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines